218 related articles for article (PubMed ID: 8488377)
1. [Hypercalcemia as an emergency].
Rosenmund A
Schweiz Med Wochenschr; 1993 Apr; 123(15):735-8. PubMed ID: 8488377
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia: an evidence-based approach to clinical cases.
Assadi F
Iran J Kidney Dis; 2009 Apr; 3(2):71-9. PubMed ID: 19395781
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcaemia. Management.
Selby PC; Peacock M; Marshall DH
Br J Hosp Med; 1984 Mar; 31(3):186, 188, 190 passim. PubMed ID: 6324944
[No Abstract] [Full Text] [Related]
4. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
5. Therapy of malignancy-associated hypercalcemia: 1983.
Stewart AF
Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
[TBL] [Abstract][Full Text] [Related]
6. Current management of malignant hypercalcaemia.
Stevenson JC
Drugs; 1988 Aug; 36(2):229-38. PubMed ID: 3053127
[TBL] [Abstract][Full Text] [Related]
7. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
Kovacs CS; MacDonald SM; Chik CL; Bruera E
J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127
[TBL] [Abstract][Full Text] [Related]
9. Conventional treatment of hypercalcemia of malignancy.
Davidson TG
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S8-15. PubMed ID: 11757206
[TBL] [Abstract][Full Text] [Related]
10. [Combination therapy with pamidronate and calcitonin in hypercalcemic crisis caused by primary hyperparathyroidism].
Christensen JH; Kristiansen JH
Ugeskr Laeger; 1992 Nov; 154(47):3341-2. PubMed ID: 1462441
[TBL] [Abstract][Full Text] [Related]
11. [Medical treatment of malignant hypercalcemia].
Eto S; Nakano Y; Okada Y
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
[TBL] [Abstract][Full Text] [Related]
12. A practical approach to hypercalcemia.
Carroll MF; Schade DS
Am Fam Physician; 2003 May; 67(9):1959-66. PubMed ID: 12751658
[TBL] [Abstract][Full Text] [Related]
13. [Hypercalcemia].
Takemoto F
Nihon Rinsho; 2004 May; 62 Suppl 5():505-10. PubMed ID: 15197973
[No Abstract] [Full Text] [Related]
14. [Hypercalcemic crisis. Exacerbation of an existing hypercalcemia syndrome].
Hehrmann R
Fortschr Med; 1996 Apr; 114(10):118-22. PubMed ID: 8655116
[TBL] [Abstract][Full Text] [Related]
15. [Pathophysiology and treatment of malignancy-associated hypercalcemia].
Miyauchi A
Nihon Rinsho; 2006 Jun; Suppl 2():161-4. PubMed ID: 16817374
[No Abstract] [Full Text] [Related]
16. Mechanisms and treatment of hypercalcemia of malignancy.
Clines GA
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
[TBL] [Abstract][Full Text] [Related]
17. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
18. Rapid Fire: Hypercalcemia.
Carrick AI; Costner HB
Emerg Med Clin North Am; 2018 Aug; 36(3):549-555. PubMed ID: 30037441
[TBL] [Abstract][Full Text] [Related]
19. Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
Blind E; Raue F; Meinel T; Wüster C; Ziegler R
Horm Metab Res; 1993 Jan; 25(1):40-4. PubMed ID: 8428711
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of malignancy-associated hypercalcemia].
Endo I; Inoue D
Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
